[1] |
Bousson V, Moretti JL, Weinmann P, et al. Assessment of malignancy in pulmonary lesions:FDG dual-head coincidence gamma camera imaging in association with serum tumor marker measurement[J]. J Nucl Med, 2000, 41:1801-1807.
|
[2] |
Ak I, Blokland JAK, Pauwels EKJ, et al. The clinical value of 18FDG detection with a dual-head coincidence camera:a review[J]. Eur J Nucl Med, 2001, 28:763-772.
|
[3] |
Delbeke D, Sandler MPl. The role of hybrid cameras in oncology[J]. Semin Nucl Med, 2000, 30:268-280.
|
[4] |
Patton JA, Turkington TG. Coincidence imaging with a dual-head scintillation camera[J]. J Nucl Med, 1999, 40:432-441.
|
[5] |
Ruhlmann J, Oehr P, Biersack HJ, et al. PET in oncology[M]. Berlin:spriger, 1999. 10-14.
|
[6] |
Lowe VJ, fletcher JW, Gobar L, et al. Prospective investigation of positron emission tomography in lung nodules[J]. J Clin Oncol, 1998, 16:1075-1084.
|
[7] |
Bar-Shalom R, Valdivia AY, Blaufox MD, et al. PET imaging in oncology[J]. Semin Nucl Med, 2000, 30:150-185.
|
[8] |
Bury T, Dowlati A, Paulus P, et al. Whole-body 18F-FDG positron emission tomography in the staging of non-small cell lung cancer[J]. Eur Respir J, 1997, 10:2529-2534.
|
[9] |
Drane WE, Abbott FD, Nicole MW, et al. Technology for FDG-SPECT with a relatively inexpensive gamma-camera[J]. Radiology, 1994, 191:461-465.
|
[10] |
Martin WH, Delbeke D, Patton JA, et al. Detection of malignancies with SPECT versus PET, with 18F-fluorodeoxyglucose[J]. Radiology, 1996, 198:225-231.
|
[11] |
Shreve PD, Steventon PS, Deters EC, et al. Ocologic diagnosis with 18F-fluorodeoxyglucose imaging:dual-head coincidence gamma camera versus positron emission tomogaphic scanner[J]. Radiology, 1998, 207:431-437.
|
[12] |
Tatsumi M, Yutani K, Watanabe Y, et al. Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer:comparison with FDG PET[J]. J Nucl Med, 1999, 40:566-573.
|
[13] |
Delbeke D, Patton JA, Martin WH, et al. FDG PET and dual-head gamma camera positron coincidence detection imaging of suspected malignancies and brain disorders[J]. J Nucl Med, 1999, 40:110-117.
|
[14] |
Weber W, Young C,. Abdel-Dayem HM, et al. Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma camera[J]. J Nucl Med, 1999, 40:574-578.
|
[15] |
Higashi K, Ueda Y, Seki H, et al. Fluorine-18-FDG imaging is negative in bronchioloalveolar carcinoma[J]. J Nucl Med, 1998, 39:1016-1020.
|
[16] |
Kapucu LO, Meltzer CC, Townsend DW, et al. Fluorine-18-fluorodeoxyglucose uptake in pneumonia[J]. J Nucl Med, 1998, 39:1267-1269.
|
[17] |
Israel O, Keidar Z, Iosilevsky G, et al. The fusion of anatomic and physiologic imaging in the management of patients with cancer[J]. Semin Nucl Med, 2001, 31:191-205.
|